Objectives: To functionalise novel chlorhexidine (CHX) particles with iron oxide (Fe3O4) nanoparticles and control their release kinetics in a dental resin using an external magnetic field.
Introduction
Antibacterial agents and their delivery are of great importance in medicine and dentistry, since a wide range of bacterial infections are still the major reasons for recurrent/ persistent infections despite the use of antibiotics [1, 2] . Biomaterial implants used in modern medicine for functional restorations are also susceptible to infections, which can lead to failure [3] . Increased application of implants in dentistry has led to significant numbers of patients developing periimplantitis (47.1% prevalence with mean functional loading of 10 years) [4] . These painful infections are caused by anaerobic bacteria and lead to bone loss, exposure of titanium implant threads and ultimately implant removal. Painful surgical treatment, smoothing of the implant [5] and cleaning together with antibiotic therapy can be carried out, but many of these treatment strategies have poor outcomes [6] . The site of bacterial infections can also be largely inaccessible to antimicrobial agents used in the oral cavity, especially in periodontal pockets and proximal/marginal areas of composite restorations, which are susceptible to bacterial micro-leakage. This can lead to the establishment of bacterial biofilms causing secondary caries, inflammation and degradation of the polymer composite [7] . Bacteria may become resistant if the antibacterial agents cannot penetrate the biofilm and if sufficient drug is not available at the infection site [8, 9] . Therefore efficient delivery and penetration of the antibacterial agent to the exact site of infection is highly desirable. In some infection, enhanced antimicrobial drug delivery might be achieved by using a non-invasive external magnetic force to improve drug navigation to the infection site. Magnetic field navigated drug delivery is based on the use of magnetic nanoparticles such as magnetite, strontium ferrite, manganese ferrite and others [10] embedded into different nano-/micro-carriers or used directly, and various therapeutic agents have been loaded for magnetic targeted delivery [11] [12] [13] [14] . Recent studies have demonstrated that by using a magnetic field superparamagnetic iron oxide nanoparticles are able to target infection sites, inhibit several bacterial functions and penetrate biofilms; thereby overcoming the therapeutic barrier often encountered when using traditional antibiotics or other antibacterial agents [3, 9] . In dentistry, magnetic nanoparticles have been incorporated into polymeric scaffolds or cement composites to enhance cell adhesion and osteogenic differentiation [15] [16] [17] and have been navigated inside dental tubules via an external magnetic field for treating dental hypersensitivity [18] . Magnetic nanoparticles are also combined with other components to enhance their antibacterial performance. Mahmoudi et al., reported coreshell nanoparticles consisting of a superparamagnetic core and silver shell, which showed enhanced antimicrobial activities and excellent penetration of biofilms when an external magnetic field was applied [19] .
CHX is a bis-biguanide antiseptic and disinfectant extensively used in medicine and dentistry [20, 21] . The current authors previously developed a novel formulation of CHX with a controllable crystal size [22] and release behavior when incorporated into a dental resin [23] .
Functionalisation of the novel CHX particles with gold nano-rods resulted in the ability to produce a near-infrared light (NIR) responsive CHX release [24] . With the ability to move CHX to an infection site using an external magnetic field, the combination of magnetic nanoparticles with CHX crystals could extend the range of antibacterial applications and improve efficacy. Therefore we aim to functionalise the novel CHX particles with iron oxide nanoparticles (Fe3O4) and investigate the possibility of moving the resulting CHX composite in a dental resin with an external magnetic field. There are many clinical situations where a targeted drug release would be desirable in restorative dentistry, periodontology and medicine.
Magnetic responsive CHX formulations may be particularly useful in developing magnetic targeted antibacterial materials.
Materials and Methods

Magnetic nanoparticles synthesis
Iron oxide nanoparticles (Fe3O4) were synthesized according to a well-established Massart's co-precipitation method [25] . Briefly, 2.35g FeCl3 (Fluka, 44944, Lot: 30607125) and 0.86g FeCl2 (Fluka, 44939, Lot: 24606139) were added in 40 ml H2O in a three-neck flask, and then placed in an oil bath and heated up to 80 o C in an argon atmosphere. The mixture was next stirred using a magnetic stirrer (VWR Stirrer, USA), at a rate of 800 rpm, whilst 5 ml NH4OH
(Sigma-Aldrich, UK, lot: 320145) was added slowly with a syringe. Heating was maintained at 80 o C for 30 mins and then 2 ml of 0.5g/ml citric acid (Sigma-Aldrich, UK, 27490, Lot:
23405C03) was introduced. The temperature was next raised to 95 o C and held for 90 mins.
The product was cooled and dialysed against H2O in a 14 kDa cut-off membrane (SigmaAldrich, UK, D9527) for one week. The Fe3O4 nanoparticles were then characterized using transmission electron microscopy (TEM) (JEOL-JEM 2010, USA) at acceleration voltage of 200 kV.
Fe 3 O 4 -Chlorhexidine sphere synthesis
Spherical CHX particles (SCPs) were functionalized with Fe3O4 nanoparticles and prepared by mixing 200 µl of Fe3O4 nanoparticle suspension with 1 ml of 0.33M CaCl2 (Sigma-Aldrich, UK, C8106, Lot: SLBF7416V). The mixture was added to 1 ml of 15 mg/ml CHX-diacetate solution (Sigma-Aldrich, UK, C6143, Lot: 19H0417). The mixtures were shaken for 1 min, and then centrifuged at 2000 rpm for 1 min (Eppendorf centrifuge, 5417C, Germany). To reduce the dissolution of the particles, the precipitates were washed three times with 0.33M CaCl2 solution. All the supernatants were collected for UV-Vis absorbance (Wavelength = 254 nm). The functionalized CHX spheres (CHX/Fe3O4) were freeze dried (ScanVac Cool Safe Freeze Drying, Denmark) at -107 o C, 0.009 mBar for 1 day. The proportion of CHX in the powders was calculated using both UV-Vis (Lambda 35, Perkin Elmer, USA) and thermogravimetric analysis (TGA Q50) as described in our previous work [23] . Control SCPs (without Fe3O4 nanoparticles) were synthesized by co-precipitation of CaCl2 and CHX-diacetate, as described in our previous study [26] . 
Preparation
UV/VIS Spectroscopy
The release kinetics of CHX from the resin discs was measured using UV-Vis absorption (Lambda 35, Perkin Elmer, USA). All the UDMA-HEMA resin discs containing CHX/Fe3O4 spheres were kept in cuvettes containing 2 ml deionized water at room temperature. Specimen Groups 1, 2 and 3 (n=3 per group) were tested at time points of 1h, 3h, 5h, 15h, 25h, 40h, 65h, 95h, 140h, 205h, 275h, 350h, 500h and 650h. Solutions from each time interval were collected for the UV-vis absorbance test and replaced with fresh deionised H2O. The released CHX for each time point was determined according to an established calibration curve [23] . Residual CHX in all the supernatants was determined by measuring the UV absorption of the supernatants at 254 nm. Cumulative release for each of the groups was plotted and compared.
Scanning electron microscopy (SEM) characterization
The spherical CHX particles, CHX/Fe3O4 spheres and resin discs containing CHX/Fe3O4 spheres (Groups 1-3) were characterised using SEM. The resin discs containing CHX/Fe3O4 spheres were immersed in liquid nitrogen and fractured to analyse the distribution of spheres.
All the samples were gold coated for 45s at 18 mA, 0.04 mBar using a sputter coater (SC7620, Emitech, UK) and viewed using a scanning electron microscope (FEI Inspect-F, USA), in the secondary electron imaging mode, with an accelerating voltage of 10 kv and spot size of 3.5.
To identify the presence of Fe in the CHX/Fe3O4 spheres, energy dispersive X-ray spectroscopy (EDX), (INCA, Oxford Instruments, High Wycombe, UK) was used with an accelerating voltage of 20 kV, working distance of 10 mm and spot size of 5. Back scattered SEM images were also used to illustrate the distribution of Fe in the CHX/Fe3O4 spheres.
To determine the influence of Fe3O4 nanoparticles on the size of spherical CHX particles, the Mean (SD) particle diameter of the spherical CHX particles and functionalized CHX particles (CHX/Fe3O4) were measured using quantitative image analysis software (Nano Measurer, version 1.2) of the SEM images.
Resin discs containing CHX/Fe3O4 spheres with 0 mins (Group 1), 5 mins (Group 2) or 10 mins (Group 3) magnetic exposure were characterized using SEM using the above protocol.
To acquire a panoramic image, cross-sectional SEM images were taken continuously from one side of the resin disc to the other side and then all the individual images were assembled to In order to assess the influence of magnetism on particle distribution the number of CHX/Fe3O4 particles in each frame (n=3 in each of the three test groups) were statistically compared using a one way ANOVA (p<0.05, Tukey test, Sigma stat, version 2.03, SPSS Inc.).
Cytotoxicity Assay
The Cytotoxicity of CHX/Fe3O4 spheres were evaluated with a standard MTT ( 25μl of each CHX/Fe3O4, CHX and pure Fe3O4 nanoparticle concentration was added into respective 96-well flat-bottomed microtiter plates to achieve a final CHX/Fe3O4, CHX and pure Fe3O4 nanoparticle concentration range of 0.0000625 % to 0.008 %. 25μl of sterile deionized water were added into the control wells (cells only and medium only) and plates were incubated for 24 hours. Culture medium containing the treatments was then removed and 50 μL of 1 mg/mL tetrazolium salt MTT (Sigma-Aldrich, Gillingham, UK) was added to each well and incubated in 37 °C for 2 hours. Formazan crystals generated by mitochondrial enzyme activity were then dissolved by 100 µl of isopropanol and the intensity of the purple coloured reaction product was quantified by measuring the absorbance spectra with a plate reader at 570
nm. The absorbance of untreated cells was considered to be 100%. Relative cell viability was calculated as: (absorbance of treated cells/absorbance of untreated cells) x 100%. Finally, an inverted microscope (Nikon Eclipse TE2000-S, UK) was used to image the morphology of treated and untreated cells.
Antimicrobial Assay
Oral pathogenic bacterium, Porphyromonas gingivalis (strain W50) was used to evaluate the antibacterial activity of CHX/Fe3O4. P. gingivalis was grown on blood agar (Blood Agar Base
No. 2; Oxoid, UK) plates in an anaerobic atmosphere (10% H2, 10% CO2, and 80% N2) at 37°C for 48 hours. The bacterial culture was harvested and suspended in brain heart infusion (BHI) broth (CM1135; Oxoid, UK) supplemented with 5µg/ml haemin and 5µg/ml menadione bisulphite. The bacterial culture was then grown for 24 hours anaerobically after which it was adjusted to an initial optical density (OD) of 0.1 at 600 nm (OD600nm) Formazan crystals were then dissolved with 100 µl of isopropanol and absorbance was measured at 570 nm. Bacterial viability was calculated as: absorbance of treated bacteria/absorbance of untreated bacteria x 100%.
Results
Results of the TEM study
TEM image of synthesized Fe3O4 nanoparticles is showed in Figure 1 . It can be seen that the mean diameter (SD) of the nanoparticles is 13.1 (2.4) nm and they appeared in clusters.
Results of the SEM study
SEM photomicrographs of the SCP and CHX/Fe3O4 spheres is shown in Figure 2a , e and 2b, f. Spherical CHX particles were produced by co-precipitation of chlorhexidine diacetate and
CaCl2. Both samples showed a porous structure and particles were monodispersed (Figs. 2a-f ).
The mean (SD) diameter for SCP was 17.15 (1.99) µm, whilst the CHX/Fe3O4 spheres had a mean (SD) diameter of 10.39 (2.61) µm. SEM photomicrographs at high magnification (×40,000) indicated a dendritic structure for both particles (Figs. 2c-d ), but Fe3O4 nanoparticles appeared dispersed within the structure for the functionalized particle (Fig. 2d) . SEM images in the back scattered mode illustrated the presence of Fe in the CHX/Fe3O4 spheres (Fig. 2f) , which was not present in the SCP (Fig. 2e) and peaks for Fe were clearly identified using EDX (Fig. 3) . (Fig. 5a) , the CHX/Fe3O4 spheres were homogeneously distributed throughout the resin discs. The Group 2 and 3 specimens (5 and 10 mins magnetic exposure) resulted in the clustering of many of the CHX/Fe3O4 spheres at the magnet end (Figs. 5b, c) . According to the numbers of magnetic CHX/Fe3O4 spheres counted in each of the frames, their distribution was plotted as a function of distance from the magnet (Figs. 6 a, b, c) . To gauge the effects of the magnetic field the percentage of particles in the first three frames (nearest the magnet) and in the disc with no treatment are listed. Group 1 frames were; 1: 8.4 %, 2: 3.6 % and 3: 7.1 % (Fig 6a) . Group 2 (5 min magnetic exposure) frames were; 1: 22.9%, 2: 20.8%, 3: 7.1% and Group 3 (10 min magnetic exposure) were 1: 38%, 2: 19.3% and 3: 5.5% (Figs 6 b, c) . The results of the statistical analysis of particles in the SEM frames (1-3) were highly significant (p<0.01) and are given in Table 1 . The power of the performed test with alpha was 0.050:1.0.
Results of the Thermo-gravimetric analysis
The results of the TGA analysis are shown in Figure 4 . The spherical CHX particles (SCP) had 8.5 wt.% remaining after increasing the temperature to 800 o C [24] , and for the Fe3O4 functionalized CHX spheres there was 33 wt.% remaining.
Release kinetics of CHX from resin
The release of CHX from the HEMA-UDMA resin discs containing functionalized CHX/Fe3O4 spheres (Groups 1-3), demonstrated a two stage process (Fig. 7) . In the first stage there was a burst release (until 200 h) which was more rapid for Groups 2 and 3 when compared to Group 1. The second stage of the plots demonstrated a sustained release for all groups. Group 1 (no magnetic treatment) resulted in 4.4% CHX released, whilst Group 2 (5 min magnetic treatment) gave 5.9% CHX released and Group 3 (10 min magnetic treatment) resulted in 7.4% CHX released at 650 h.
Cytotoxicity Assay Results
The results of the cytotoxicity assay are presented in Figure 8a . (Fig.8a) . Accordingly, changes in cellular morphology (rounded, swelled, and loss of attachment to the wells) were also observed in both 0.0005% and 0.001% CHX treated cultures, whilst the normal morphology was maintained in CHX/Fe3O4 sphere treated cultures ( Fig. 8b-d ). Figure 9 shows the antimicrobial activity of CHX/Fe3O4 against P.gingivalis. The growth of P. gingivalis was completely inhibited by 0.0005% wt./vol. CHX/Fe3O4 (MIC) (Figure 9a ) as measured by culture optical density. The MTT assay also confirmed this MIC value with no viability being detected at 0.0005% wt./vol. CHX/Fe3O4 (Figure 9b ).
Antimicrobial Assay Results
Discussion
The antibacterial activities of metal nanoparticles such as gold, silver, copper, zinc and titanium and their applications against bacterial infections are well established [27] . In the current study Fe3O4 nanoparticles with an mean (SD) diameter of 13.1 (2.4) nm (Fig. 1) were synthesized using a co-precipitation method to take advantage of their ferrimagnetic properties [28] and allow targeted CHX drug release. Magnetic nanoparticles are extensively used for targeted drug delivery and as diagnostic agents due to their excellent magnetic properties, superior biocompatibility and ease of functionalization [14] . Magnetite (Fe3O4) is an inverse spinel structure with various particle morphologies that include spherical, octahedral or cubic structures [29] . The cubic structure is known to grow via a screw dislocation process [30] . In this study TEM of the precipitated Fe3O4 nanoparticles appeared to show signs of spherical morphology, although this was indistinct. The shape, size and surface chemical functionalities of iron oxide nanoparticles have a profound effect on their antibacterial activities [3] . When tested, CHX/Fe3O4 demonstrated antimicrobial activity against the periodontal pathogen P.
gingivalis (Fig. 9) . Importantly the cytotoxicity assay results showed that the CHX/Fe3O4 treated cells maintained >90% viability at the concentration that inhibited bacterial growth (Fig.   8a ). Furthermore, Fe3O4 nanoparticle alone treated cells demonstrated >90% viability even in the highest treatment concentration tested (0.008%), whilst commercial CHX diacetate treated cells were not viable. This demonstrates that Fe3O4 nanoparticles were not cytotoxic to the fibroblastic cells (Fig. 8a) . Magnetic targeted superparamagnetic iron oxide nanoparticles have been shown to be active against Staphylococcus epidermidis biofilms and may be an effective alternative to antibiotics for antibiotic-resistant strains [3] . They also appear more effective in penetrating and inhibiting biofilms compared with traditional antibiotics [9] . The antibacterial mechanisms associated with metal nanoparticles include their electrostatic attraction to the negatively charged bacterial cell membrane, their high surface area to volume particle ratio [31] and production of a reactive oxygen species, ensuring intimate membrane contact and leading to functional disorder of the bacterial cells [3] . The dynamic series of interfacial interactions between nanoparticles and biological structures are however very complex [32] .
The crystallization of the CHX compound onto the Fe3O4 nanoparticles in the present study is advantageous as it presents an opportunity for a dual and tailored antibacterial effect. Enhanced antibacterial activity might also be obtained through the release of Fe3O4 nanoparticles through the dissolution of CHX from the sphere structure. Such a possibility would be valuable in treating antibiotic resistant bacterial biofilms but remains to be demonstrated.
Functionalization of the CHX spheres using the Fe3O4 nanoparticles appeared to dramatically decrease the mean (SD) CHX particle diameter from 17.15 (1.99) µm for the particles with no functionalization (Figs. 2a, 2e ) to 10.39 (2.61) µm for the CHX/Fe3O4 spheres (Figs. 2b, 2f) .
However, the spherical morphology and structure appeared unchanged (Figs. 2c-f ). These metal ions may also act as sites for CHX crystallization, where the co-precipitation system encourages surface crystallization. Previous work indicated that functionalizing the CHX spheres with gold nanorods resulted in correlation between the number of nanoparticles added and the mean CHX particle diameter and number (r 2 =0.98) [24] . It is hypothesized that this might be possible with a number of metal ions including Fe3O4. The present work was directed towards the magnetic properties associated with ferrimagnetic domains in the Fe3O4 structure (tetrahedral and octahedral sub-lattices) [29] , enabling a magnetic responsive drug release behavior. The Fe3O4 nanoparticles identified in this study are known to interact with each other and problems have been posed with functionalizing these particles for different applications [33] . Domains of the excess Fe3O4 nanoparticles were identified trapped within the CHX crystal structure (Figs. 2d, 2f, 3) , which enhanced the magnetic effect and allowed the CHX/Fe3O4 particle movement.
The spherical CHX particles produced by co-precipitation of CaCl2 and chlorhexidine diacetate had a very high drug content (> 90 wt.%). After TGA analysis (Fig. 4 ) the remaining weight of the spherical CHX particles was 8.5 wt.%, which was ascribed to the presence of CaCl2 and chlorhexidine diacetate/degradation products [23] . When the CHX particles were functionalized with Fe3O4 nanoparticles, the remaining weight increased to 33 wt.% (Fig. 4) , which was due to the non-decomposing metal nanoparticles at high temperature. Therefore 24.5 wt.% of Fe3O4 nanoparticles were calculated to have been incorporated into the CHX particles and this proportionally reduced CHX content may be the reason for the reduced cytotoxicity observed against fibroblastic cells in comparison with CHX at the same concentration (Fig. 8 ).
Magnetic nanoparticles are largely incorporated within carriers together with drugs resulting in a low drug loading rate [34] . The current strategy overcomes this problem as it was possible to grow the CHX drug (67 wt.%) directly onto the surface of metal nanoparticles and trap them within its structure (Figs. 2d, 2f ). There are many studies using magnetic nanoparticles for targeted delivery, but this is the first study to integrate magnetic nanoparticles directly into drug crystals. This method promotes intimate contact between the metal nanoparticles and CHX crystals that can improve both plasmonic [24] and magnetic sensitivity, broadening the range of drug delivery methods. This also allows the potential of varying the Fe3O4 nanoparticle content to tailor these properties and to control the size, number and CHX/ Fe3O4 sphere ratio via particle crystallisation.
Functionalization of the CHX spheres allowed the particles to be moved in the viscous HEMA-UDMA resin in response to application of an external magnetic force (Figs. 5b, 5c ). The resin sample without magnetic exposure presented a homogeneous distribution of CHX/Fe3O4 spheres across the SEM cross sectional samples (Figs. 5a, 6a ), which were evenly distributed by the resin mechanical mixing prior to curing. There was also no statistical difference (p>0.05) between the number of spheres present in SEM frames 1-3 indicating this to a depth of 141 microns. Following magnetic exposure (5 and 10 mins) there was a significant increase (p<0.01) in the number of CHX/ Fe3O4 spheres to a depth of 94 microns from the surface (Fig 5b, 5c, 6b, 6c) nearest to the magnet. This represented 43.7%-57.3% of the CHX/ Fe3O4 spheres in the samples (Figs. 6 b, 6c) . At a depth >94 microns (Frames 3, Figs. 5b, 5c ) from the surface nearest the magnet the CHX/ Fe3O4 sphere number was reduced and not significantly different to the CHX/ Fe3O4 sphere distribution (frame 3, group 1) with no magnetic exposure ( Table 1, P>0.05). Clearly with magnetic exposure there was bulk movement of the CHX/ Fe3O4 spheres towards the magnet. The strength of the magnetic field was a key factor, and the magnetic field currently used was 400 mT at the magnet surface. Magnetic field strength has been shown to drop rapidly as a function of distance from the surface for Fe3O4 nanoparticles incorporated in microcapsules (1.3 um diameter) and dispersed in cell suspensions [35] . The current work synthesis of cubic nanoparticles could also affect their magnetic sensitivity [36] , allowing a stronger magnetic field to be used to reduce the exposure time. Guardia et al [37] suggested that cube-shaped (polydispersity <20%) Fe3O4 nanoparticles (19 nm) were in the transition between superparamagnetic and ferromagnetic particles, which yields high magneto-thermal
properties. The magnetic attraction of CHX/ Fe3O4 spheres and their directed movement through a dental polymer or gel is extremely desirable, as it allows the drug to be moved to the infection site to potentially kill the bacteria more efficiently. Antibacterial agents of this kind navigated by an external magnetic field resulted in an 8-fold higher antibacterial effectiveness in comparison to using antibiotics [3] . The current CHX/ Fe3O4 spheres might therefore be effective in sites in the oral cavity inaccessible to current antimicrobial agents, such as deep periodontal pockets or sites susceptible to secondary caries.
The release kinetics of CHX/ Fe3O4 spheres from the HEMA-UDMA resin demonstrated a twostage process. Utilising a magnetic field (5 and 10 mins) to draw the CHX/ Fe3O4 spheres to the surface appeared to have the effect of inducing a more rapid drug release in the initial stages (until 200 h) from 2.9% (no magnetic field) to 4.0% (5 min) or 4.5% (10 min) (Fig. 7) .
Near surface drug entrapment and rapid leaching in water explains this burst effect [38, 39] .
Inhibition of the polymerisation process by the increased CHX content in the near specimen surface (94 µm) and the presence of residual monomers /unreacted hydrophilic components encouraging water sorption of the polymer [40, 41] . After a 650 h sustained CHX release the overall drug content was also increased from 4.4% to 7.4% (10 min magnetic exposure). Most of the CHX incorporated in the Group 1 resin discs remained in the resin due to the homogeneous distribution of CHX/ Fe3O4 spheres throughout the sample interior (Group 1, Fig 5a) , which limited the volume fraction of CHX/ Fe3O4 spheres available for rapid dissolution and diffusion mechanisms near the surface [41] . Synthesis of spherical CHX particles (without functionalization) by co-precipitation of CaCl2 and chlorhexidine diacetate indicated that the particles were stable, less soluble and with lower CHX release rates than the chlorhexidine diacetate counterpart when dispersed in resin [23] . This can be attributed to Cl -ions in their structure [42] and has been linked to the CHX release kinetics [22] . Following application of a magnetic field for 5-10 mins the CHX/ Fe3O4 spheres (43.7%-57.3%) were drawn to a depth of 94 microns from the surface of the polymer (Fig 5b, 5c, 6b, 6c ). The diffusion of CHX is determined by the water droplets formed around the drug particles, which form pathways or channels linked to the surface [43] . It is therefore not surprising that the resin discs with more CHX/ Fe3O4 spheres distributed near the surface had higher release rates.
Mechanisms for CHX/ Fe3O4 sphere dissolution appeared to be via the central part of the particle which was more prevalent for spheres nearer the resin surface than the interior. This dissolution behavior was thought to be associated with the penetration and intimate contact between the resin and the interior CHX/ Fe3O4 sphere structure [23] . The magnetic CHX/ Fe3O4 spheres embedded in resin could therefore also be further triggered with an alternating magnetic field to induce a responsive release [33, 44, 45] , which will be explored in future work.
The functionalized CHX spheres (CHX/ Fe3O4) have a number of potential applications and this is the first study to demonstrate novel magnetic functionalized CHX particles, where their distribution in a resin can be manipulated with an external magnetic field to alter the CHX release kinetics. These particles could be incorporated into dental filling materials and used to restore exposed implant surfaces or dispersed into maxillo-facial/ denture lining materials, allowing magnetically directed and drug responsive properties. These magnetic CHX/ Fe3O4 spheres dispersed in gels and varnishes etc. are particularly attractive for the treatment of persistent periodontal or biomaterial-implant-associated infections. List of Tables   Table 1, Mean (SD) CHX/Fe3O4 particle distribution in the cross-sectional SEM photomicrographs, frames 1-3 (figures based on n=3 panoramic SEM images per test group). 
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